Medison Pharma Lithuania UAB Finance - revenue, profit
Financial ratios
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 1,652,238 |
| 200,758 |
| 77,271 |
| 61,984 |
| 7,531 |
| 29.19 |
| 3.75 |
| 136,048 |
| 239,716 |
| 60,186 |
| 503,831 |
| 2024 |
|---|
| 2,249,347 |
| 212,003 |
| 116,256 |
| 90,317 |
| 8,512 |
| 38.07 |
| 4.02 |
| 226,365 |
| 281,915 |
| 42,621 |
| 760,971 |
| 2025 |
|---|
| 2,422,514 |
| 184,222 |
| 154,507 |
| 132,500 |
| 10,076 |
| 37.10 |
| 5.47 |
| 358,865 |
| 613,380 |
| 65,924 |
| 1,052,983 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 2,422,514 |
| 184,222 |
| 154,507 |
| 132,500 |
| 10,076 |
| 37.10 |
| 5.47 |
| 358,865 |
| 613,380 |
| 65,924 |
| 1,052,983 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
2,422,514 €8 % *
Sales per employee (€)
184,222 €-13 % *
Profit before tax (€)
154,507 €33 % *
Net Profit (€)
132,500 €47 % *
Profit per employee (€)
10,076 €18 % *
Total profitability (%)
37.10 %-2.55 % *
Net profitability (%)
5.47 %36.07 % *
Equity (€)
358,865 €59 % *
Amounts Payable And Liabilities (€)
613,380 €118 % *
Non-current Assets (€)
65,924 €55 % *
CurrentAssets (€)
1,052,983 €38 % *
